Advisory Panel Shelves Decision on Avigan, Says No Clear Efficacy Shown for COVID-19

A key health ministry advisory committee on December 21 put a hold on its decision on whether to back approval for Fujifilm’s antiviral Avigan (favipiravir) for the treatment of COVID-19, saying that it is “difficult to conclude the drug’s clear...read more